Mead Johnson & Co. Patent applications |
Patent application number | Title | Published |
20100105083 | Methods For Determining The Levels Of TGF-Beta In A Composition - A novel method for determining the levels of TGF-β1 or TGF-β2 in a sample of milk, raw protein source, or nutritional composition is provided. The method involves, in some cases, reconstituting the sample; in some cases, centrifuging the sample; activating the sample using particular ratios of sample:acid:base; diluting the sample using particular ratios of sample:buffer agent; and determining the concentration of TGF-β1 in the sample using an ELISA assay. | 04-29-2010 |
20100105080 | Methods For Determining The Bioactivity Of TGF-Beta In A Composition - A novel method for determining the bioactivity of TGF-β in a sample of milk, raw protein source, or nutritional composition is provided. The method includes particular reconstitution steps, centrifugation steps, incubation steps, and activation steps. The bioactivity of the TGF-β in the sample may be measured in a HT-2 cell bioassay or a cellomics bioassay. | 04-29-2010 |
20100104727 | Methods For Preserving Endogenous TGF-Beta - The present invention is directed to a processing method and a selection of ingredients that will retain TGF-β levels, bioactivity, and/or bioavailability in a liquid nutritional product. | 04-29-2010 |
20100104696 | Nutritional Composition With Improved Digestibility - The present invention is directed an improved nutritional composition, methods of improving digestion, and methods of enhancing the bioavailability of TGF-β. | 04-29-2010 |
20090176734 | Method For Simulating The Functional Attributes Of Human Milk Oligosaccharides In Formula-Fed Infants - The present invention is directed to a novel method for increasing the production of acetate, decreasing the production of butyrate, increasing the population and species of beneficial bacteria and slowing the rate of fermentation of prebiotics within the gut of a formula-fed infant. The method comprises administration of a therapeutically effective amount of PDX to the infant. | 07-09-2009 |